Gilead Sciences (GILD) Stock Analysis

OW

GILD Equity Research — OVERWEIGHT — June 2026

Rating date

Jun 16, 2026

55 days ago

Desk view

OW

5D move

Awaiting market data

Peer rank

56p

Investment card · GILD

Over the trailing 12 months (June 2025 → June 2026), GILD staged a powerful rally from roughly $103 to a multi-year peak near $136 (May 28–29, 2026). However, the final month tells a different story. Since late May, the stock has erased ...

Desk rating

OW

Tactical OW · 12M OW

Horizon

Long-term

Confidence

Medium

Invalidation

Thesis weakens if catalysts slip or risk markers breach stated levels.

Bias

OVERWEIGHT

Catalysts

  • Near-term trend has decisively turned bearish — price broke below both the 50-day and 200-day SMAs, and MACD is in a deepening bearish phase.
  • The long-term uptrend is under threat — while the 200-day SMA is still rising, the 50-day SMA is falling rapidly and approaching it. A death cross would be a major technical deterioration.
  • RSI bounced from oversold but needs to clear 50 to signal genuine bullish re-engagement. Currently at 46.7, the RSI indicates recovery without conviction.

Risks

  • Event-driven repricing risk if expectations diverge from incoming evidence.

Market chart

Price context alongside the research narrative.

GILD Research Note

Full desk note for Jun 16, 2026. Use tabs for catalysts, valuation and risks, or open the full note.

29 min read

WebserviceX · Agentic Research Desk

GILD Equity Research Note

Published Jun 16, 2026 · Desk view OVERWEIGHT · Generated 2026-06-17T07:02:40Z · Maintained by Walter Vijayakumar · Methodology · Track record

GILD Stock Rating Summary

GILD bias

OVERWEIGHT

Horizon

Long-term

GILD key risk

Event-driven repricing risk if expectations diverge from incoming evidence.

GILD catalyst watch

Near-term trend has decisively turned bearish — price broke below both the 50-day and 200-day SMAs, and MACD is in a deepening bearish phase.

Invalidation

Thesis weakens if catalysts slip or risk markers breach stated levels.

Confidence

Medium

How the call aged · 5D

Awaiting market dataPeer 56p
Expand

Grading rule: BUY/OVERWEIGHT scores Correct when forward return > 0; UNDERWEIGHT/SELL when < 0; HOLD is Neutral. Window uses 5 US trading sessions after the rating entry close vs benchmark SPY. Scorecard computed 2026-06-17T07:48:26.165574+00:00.

5D move

2026-06-16 → awaiting

Outcome

Awaiting market data

5D trend

+2.04%

Vol (20D ann.)

+28.22%

vs SPY: +0.24%

Close 127.23 (USD, vendor closes)

Batch scorecard · 2026-06-16 · GILD

Publish QC

passed
Expand

Pipeline fingerprint 2f45a102687f75c0

Trace 2b8ed439

No QC issues recorded.